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Physiological characteristic function in the 
liver of ruminant
The liver is an important organ that adjusts metabolism 
according to the nutrients it takes in, leading to its own 
biological maintenance and growth. The primary functions of 
the liver include glucose metabolism, protein metabolism, lipid 
metabolism, regulation and detoxification of ion gradients, and 
bile production and secretion; these functions are so diverse 
that they are often compared to those in chemical factories.
Endocrine research in livestock has significantly contributed 
to the elucidation of the molecular mechanisms of livestock 
production traits such as lactation, meat production, and 
reproduction, which are based on nutrient metabolism. Recent 
studies have revealed that various organs and tissues other than 
the classical endocrine glands secrete peptides and cytokines. 
Therefore, current endocrinology is undergoing a paradigm 
shift from being a simple model of regulation of metabolic 
organs by endocrine glands to a metabolic regulation network 
through hormone secretion by various tissues throughout 
the body, including the endocrine glands, and this complex 
network.
In ruminant, shortly after birth, the rumen is physically 
and functionally underdeveloped (Warner, 1956; Tamate et 
al., 1962). Like monogastric animals, ruminant take nutrients 
from milk after birth, but after weaning they take in nutrients 
produced from solid diets in the rumen. Roughage contributes 
to rumen development by providing physical stimulation; 
consequently, short-chain fatty acids (SCFA), which are 
fermented rumen products, contribute to this development by 
chemical stimulation.
Hepatokines
The liver has a wide range of functions, and it can be 
referred to as the largest nutrient-metabolizing organ in 
the body. Although ruminant livestock such as cattle have 
metabolic characteristics that differ from those of monogastric 
animals, they still have functionally important organs wherein 
nutrients absorbed from the rumen and small intestine are first 
metabolized. However, recent studies have revealed that the 
liver also plays a role as an endocrine organ. IGF-1 (Insulin-
like growth factor 1) is well known as an endocrine factor 
derived from the liver (Roberts et al., 1990), but new liver-
derived hepatokines such as Fetuin-A, FGF-21 (Fibroblast 
growth factor-21), Selenoprotein-P, and ANGPTLs have been 
discovered. Hepatokine has been reported to regulate systemic 
glucose metabolism, lipid metabolism, and insulin signals, 
and it is thought that the liver regulates systemic metabolism 
by issuing endocrine signals according to its own nutritional 
metabolism status.
It has been suggested that endocrine factors such as insulin 
and IGF-1 may also be involved in rumen development 
(Gerrits et al., 1998; Shen et al., 2004). Before weaning, 
glucose, long chain fatty acids (LCFA, long chain fatty 
acid), and amino acids are obtained from milk; however, 
after weaning, short chain fatty acids produced by rumen 
microorganisms are absorbed in the rumen. Before weaning, 
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The liver plays a crucial role as a secondary endocrine organ in controlling 
homeostasis. In ruminant, hepatic function changes dramatically during weaning 
and parturition through the signaling of hormones and blood metabolites. The 
management systems, feed composition, and feeding program greatly affect the 
pathological processes of energy metabolism disorders in the liver. The endocrine 
system and liver are codependent, and both can alter the quantity and quality of 
animal production. In this review, we will provide our data on the physiological 
roles of chemerin and ANGPTL8 (angiopoietin Like 8) as hepatic hormones, and the 
regulatory factors controlling their production, to better understand hepato-endocrine 
interplay.
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the liver is the main tissue for glycolysis via glucose and 
ketone body production from LCFA. However, after weaning, 
gluconeogenesis via propionate becomes more important, 
and ketone body production decreases due to the decrease 
in carbohydrate supply from feed and the influence of 
decomposition by rumen microorganisms. In this paper, I will 
discuss the physiological roles of chemerin and ANGPTL8 in 
relation to metabolic regulation in ruminant.
Chemerin
Chemerin is a chemokine-type secretory protein encoded by 
TIG2 (Tazarotene-induced gene 2), also known as RARRES2 
(retinoic acid receptor responder) (Nagpal et al., 1997). To 
date, three types of chemerin receptors have been identified: 
CMKLR1 (chemokine like receptor 1), GPR1 (G-protein 
receptor 1), and CCRL2 (chemokine (C-C motif) receptor-
like 2) (Wittamer et al., 2003; Zabel et al., 2005; Barnea et al., 
2008). The major gene expression sites of chemerin in mice 
and humans are the heart, lung, liver, spleen, kidney, pancreas, 
white adipose tissue, brown adipose tissue, placenta, and 
uterus; these sites are highly expressed, especially in the liver 
and white adipose tissue. CMKLR1 is highly expressed in the 
heart, lung, skeletal muscle, and adipose tissue. In addition, 
CCRL2 is highly expressed in the spleen and lymph nodes, 
and GPR1 is highly expressed in skeletal muscle, adipose 
tissue, and the brain (Fan et al., 1998; Rourke et al., 2014).
The physiological actions of chemerin in relation to the 
immune system, glucose metabolism, and lipid metabolism 
are well known. The immune system attracts dendritic cells, 
macrophages, and NK cells to the site of inflammation. As 
a metabolic system, insulin sensitivity of peripheral tissues, 
regulation of glucose uptake, differentiation of mature 
adipocytes from adipose progenitor cells, and regulation of 
insulin secretion have been reported (Goralski et al., 2007; 
Roh et al., 2007; Sell et al., 2009; Ernst et al., 2010; Takahashi 
et al., 2011).
Chemerin mRNA is highly expressed in adipose tissue, 
liver, kidney, adrenal gland, spleen, and small intestine, 
especially in the liver (Suzuki et al., 2016). The chemerin 
receptors (CMKLR1 and CCRL2) were expressed in various 
tissues; however, CMKLR1 was highly expressed in the 
liver, adrenal gland, spleen, and lung, and CCRL2 was highly 
expressed in adipose tissue, adrenal gland, spleen, large 
intestine, and lung. In addition, expression of GPR1 was 
observed only in adipose tissue, liver, lung, and rumen, and 
its expression was particularly high in the liver. Chemerin was 
localized in the cytoplasm of bovine hepatocytes. A previous 
report confirmed that the expression of chemerin was higher in 
adipocytes than in vascular stromal cells, but the results were 
consistent (Song et al., 2010). Compared to the expression 
level in other tissues, it is believed that the liver is the main 
endocrine organ that produces chemerin in cattle.
Chemerin has been shown to have an insulin secretagogue 
effect in sheep (Suzuki et al., 2012). Administration of a 
chemerin analog led to an acute rise in the plasma insulin 
levels and decreased glucose levels. Plasma NEFA (non-
esterified fatty acids) levels were elevated from 60 to 180 min 
after administration. Chemerin analog administration also 
transiently elevated the levels of plasma triglyceride and total 
cholesterol, suggesting increased VLDL (very low-density 
lipoprotein) secretion from the liver. Plasma HDL (high-
density lipoprotein) levels declined after administration. A 
previous study by our group showed five SNPs in the coding 
region of the bovine chemerin gene in Japanese Black cattle 
(Yamauchi et al., 2015). The c.276C>T SNP of the chemerin 
gene potentially regulates meat quality by affecting the 
composition of intramuscular fatty acids.
Since the expression of chemerin in the liver during 
the lactation period was decreased, it is expected that the 
concentration of chemerin in the blood during this period was 
decreased. It is possible that the decrease in the expression 
level of chemerin is involved in the decrease in insulin 
secretion during lactation. Throughout the lactation and dry 
stages, the cellular composition within the mammary gland 
changes significantly. Increased expression of chemerin 
receptors during the dry period may be caused by immune 
cells infiltrating the mammary gland tissue during the dry 
period. The chemerin receptors are expressed in bovine 
mammary epithelial cells, and chemerin activates the ERK 
pathway and increases the expression of milk synthesis-related 
genes. Therefore, it is believed that chemerin may have a 
lactogenic action or a growth factor-like action in mammary 
epithelial cells. However, increased expression of the chemerin 
receptor was found in mammary glands during the dry period. 
Chemerin is considered to regulate the immune system and 
metabolic system as hepatokines that are highly expressed in 
the liver and affect productivity of cattle.
ANGPTL8
ANGPTL8 is a liver-derived secretory protein that is also 
known as TD26, RIFL, Lipasin, or betatrophin. The expression 
sites of ANGPTL8 in humans and mice are liver, white adipose 
tissue, and brown adipose tissue, and its expression in other 
tissues is extremely low (Zhang, 2012). It has been reported 
that the physiological effects of ANGPTL8 are involved in 
the regulation of blood TG (triglyceride) levels, although the 
receptor for ANGPTL8 has yet to be identified. ANGPTL8 
expression in mouse liver decreases with fasting and increases 
after feeding (Ren et al., 2012). The overexpression of 
ANGPTL8 resulted in dyslipidemia (elevated blood TG), and 
knockout mice showed low TG levels (Quagliarini et al., 2012; 
Wang et al., 2013). In ANGPTL8 KO mice, adipose tissue 
development is delayed and VDL (very low density) release 
from the liver is also reduced.
Lipid metabolism in cattle is closely related to growth, 
energy storage, and supply during lactation in cattle. 
ANGPTL8 mRNA was highly expressed in liver and adipose 
tissue and was either slightly or not detected in other tissues of 
cattle (Nakano et al., 2018). ANGPTL8 protein was detected 
only in the liver. As a result, the expression of ANGPTL8 
in the liver showed no significant change throughout 
the lactation period or the dry period. The expression of 
ANGPTL8 in the liver during parturition was examined in 
the biopsied liver tissue, which showed that the expression 
of ANGPTL8 in the liver before calving was not changed; 
however, it was significantly reduced after parturition. The 
blood TG concentration was observed to be lower one week 
before calving and it reached its lowest value on parturition; 
subsequently, it decreased during the first four weeks post-
parturition, while the blood NEFA concentration was higher 
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four weeks after parturition. In dairy cattle, with the start of 
lactation, NEFA released from adipose tissue is converted to 
VLDL in its original state or in the liver and subsequently 
mobilized to the mammary gland (Drackley et al., 2001). 
Because ANGPTL8 inhibits LPL (Lipoprotein lipase) activity 
and increases blood TG concentration, it is considered that 
the changes in ANGPTL8 expression coincide with blood 
TG concentration during the parturition. Since the regulation 
of hepatic ANGPTL8 expression by insulin and fasting has 
been reported, it is considered that the decrease in ANGPTL8 
expression after parturition is due to a decrease in blood 
insulin concentration and a negative energy balance. When 
the lactation period and the dry period were compared, there 
was no difference in the expression level of ANGPTL8 in the 
liver; it is possible that cows used in the dry period were not 
pregnant. As described above, it was suggested that ANGPTL8 
is a factor that regulates lipid mobilization during lactation in 
dairy cows.
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